Ascendis unit Remedica grows revenue and earnings
The growth has been ‘driven by the launch of products in new markets and the improvement in raw material supply’
20 December 2019 - 09:30
Ascendis Health said on Friday that its subsidiary, Remedica, had delivered revenue growth of 18% in the year to November driven by the launch of new products.
The update comes after the debt-laden health and wellness company announced on Tuesday that it had terminated talks to sell Remedica...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.